Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 29878490

Outcome of children and adolescents with Down syndrome treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium protocols 00-001 and 05-001.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Pediatr Blood Cancer
Publication date
2018 Oct
First author
Athale UH

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Athale UH
      type
      Author
    2. name
      Puligandla M
      type
      Author
    3. name
      Stevenson KE
      type
      Author
    4. name
      Asselin B
      type
      Author
    5. name
      Clavell LA
      type
      Author
    6. name
      Cole PD
      type
      Author
    7. name
      Kelly KM
      type
      Author
    8. name
      Laverdiere C
      type
      Author
    9. name
      Leclerc JM
      type
      Author
    10. name
      Michon B
      type
      Author
    11. name
      Schorin MA
      type
      Author
    12. name
      Sulis ML
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Athale UH
      type
      Author
    2. name
      Puligandla M
      type
      Author
    3. name
      Stevenson KE
      type
      Author
    4. name
      Asselin B
      type
      Author
    5. name
      Clavell LA
      type
      Author
    6. name
      Cole PD
      type
      Author
    7. name
      Kelly KM
      type
      Author
    8. name
      Laverdiere C
      type
      Author
    9. name
      Leclerc JM
      type
      Author
    10. name
      Michon B
      type
      Author
    11. name
      Schorin MA
      type
      Author
    12. name
      Sulis ML
      type
      Author
    bibliography ids
    1. nci-bib-417f48619a990ed11c97b059
    book metadata
    content sha256
    d031ab5f111ed3963494bb0aa704e689c64dad7aa75efb794593e3bac0089188
    document type
    citation
    dois
    1. 10.1002/pbc.27256
    electronic publication date
    display
    2018 Jun 7
    precision
    day
    year
    2018
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:29878490
    immutable id
    pubmed:29878490@d031ab5f111ed3963494bb0aa704e689c64dad7aa75efb794593e3bac0089188
    journal
    abbreviation
    Pediatr Blood Cancer
    issn electronic
    1545-5017
    issn print
    1545-5009
    issue
    10
    name
    Pediatric blood & cancer
    nlm unique id
    101186624
    pages
    e27256
    volume
    65
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      29878490
      provenance
      batch id
      c4c0356d060413f719c2
      provider
      NCBI PubMed ESummary
      record sha256
      2d4c7b50453b08591febd671e09eb70848a625011a32d1923d5da3292e8c555a
      response sha256
      adeb6beaad718f060a94981fd9e96a2eaddc4f781839549cb3e53cba822117c0
      retrieved at
      2026-09-09T23:47:33.674758+00:00
      publication date
      display
      2018 Oct
      precision
      month
      year
      2018
      publication types
      1. Clinical Trial
      2. Journal Article
      3. Research Support, N.I.H., Extramural
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/29878490/
      title
      Outcome of children and adolescents with Down syndrome treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium protocols 00-001 and 05-001.

      Preserved source evidence · Not medical advice